345 related articles for article (PubMed ID: 25113329)
1. [Psychosomatic aspects of prurigo nodularis].
Schneider G; Hockmann J; Stumpf A
Hautarzt; 2014 Aug; 65(8):704-8. PubMed ID: 25113329
[TBL] [Abstract][Full Text] [Related]
2. REMOVED: Plasma Steroids and Endocannabinoids Used as Biomarkers to Assess the Pruritus Severity of Patients With Prurigo Nodularis.
Chu L; Wang L; Wu Y; Yang H; Wang W; Lu Q; Deng H
Actas Dermosifiliogr; 2022 Mar; 113(3):T244-T253. PubMed ID: 35331446
[TBL] [Abstract][Full Text] [Related]
3. REMOVED: Plasma Steroids and Endocannabinoids Used as Biomarkers to Assess the Pruritus Severity of Patients With Prurigo Nodularis.
Chu L; Wang LK; Wu Y; Yang H; Wang W; Lu Q; Deng H
Actas Dermosifiliogr; 2022 Mar; 113(3):244-253. PubMed ID: 35282859
[TBL] [Abstract][Full Text] [Related]
4. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study.
Schneider G; Hockmann J; Ständer S; Luger TA; Heuft G
Br J Dermatol; 2006 Jan; 154(1):61-6. PubMed ID: 16403095
[TBL] [Abstract][Full Text] [Related]
5. The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis.
Janmohamed SR; Gwillim EC; Yousaf M; Patel KR; Silverberg JI
Arch Dermatol Res; 2021 Oct; 313(8):669-677. PubMed ID: 33108524
[TBL] [Abstract][Full Text] [Related]
6. A critical review of dupilumab for adult patients with prurigo nodularis.
Biazus Soares G; Yosipovitch G
Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and interleukin-6: Association with pruritus severity, sleep quality and depression severity in Prurigo Nodularis.
Konda D; Chandrashekar L; Rajappa M; Kattimani S; Thappa DM; Ananthanarayanan PH
Asian J Psychiatr; 2015 Oct; 17():24-8. PubMed ID: 26277226
[TBL] [Abstract][Full Text] [Related]
8. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus.
Elmariah S; Kim B; Berger T; Chisolm S; Kwatra SG; Mollanazar N; Yosipovitch G
J Am Acad Dermatol; 2021 Mar; 84(3):747-760. PubMed ID: 32682025
[TBL] [Abstract][Full Text] [Related]
9. INDIVIDUAL ARTICLE: Prurigo Nodularis: Current Clinicopathologic Overview and Psychodermatological Perspectives.
Issa NT; Riva H; Jafferany M
J Drugs Dermatol; 2023 Dec; 22(12):SF365502s6-SF365502s11. PubMed ID: 38051853
[TBL] [Abstract][Full Text] [Related]
10. Prurigo nodularis: Epidemiology and clinical features.
Huang AH; Williams KA; Kwatra SG
J Am Acad Dermatol; 2020 Dec; 83(6):1559-1565. PubMed ID: 32454098
[TBL] [Abstract][Full Text] [Related]
11. Chronic prurigo.
Misery L
Br J Dermatol; 2022 Oct; 187(4):464-471. PubMed ID: 35656799
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis.
Williams KA; Roh YS; Brown I; Sutaria N; Bakhshi P; Choi J; Gabriel S; Chavda R; Kwatra SG
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):67-77. PubMed ID: 33191806
[No Abstract] [Full Text] [Related]
13. Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
Yook HJ; Lee JH
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791201
[TBL] [Abstract][Full Text] [Related]
14. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
Pereira MP; Basta S; Moore J; Ständer S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2224-2229. PubMed ID: 29869425
[TBL] [Abstract][Full Text] [Related]
15. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
Vaidya DC; Schwartz RA
Acta Dermatovenerol Croat; 2008; 16(1):38-44. PubMed ID: 18358109
[TBL] [Abstract][Full Text] [Related]
16. [Prurigo nodularis: its association with dermatoses and systemic disorders].
Mettang T; Vonend A; Raap U
Hautarzt; 2014 Aug; 65(8):697-703. PubMed ID: 25113328
[TBL] [Abstract][Full Text] [Related]
17. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
18. Association of prurigo nodularis and lichen simplex chronicus with hospitalization for mental health disorders in US adults.
Singam V; Patel KR; Silverberg JI
Arch Dermatol Res; 2020 Oct; 312(8):587-593. PubMed ID: 32078024
[TBL] [Abstract][Full Text] [Related]
19. INDIVIDUAL ARTICLE: Management of Prurigo Nodularis.
Elmariah SB; Tao L; Valdes-Rodriguez R; Laquer V
J Drugs Dermatol; 2023 Dec; 22(12):SF365502s15-SF365502s22. PubMed ID: 38051855
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis.
Kwatra SG; Rodriguez D; Dias-Barbosa C; Budhiarso I; Fofana F; Vernon M; Gabriel S; Piketty C; Puelles J
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2403-2416. PubMed ID: 37615836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
